Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1982 1
1984 1
1987 1
1990 1
1991 3
1992 4
1993 1
1997 1
1998 3
1999 3
2000 2
2001 1
2004 2
2005 3
2006 3
2007 4
2008 5
2009 12
2010 9
2011 14
2012 14
2013 16
2014 13
2015 20
2016 28
2017 16
2018 33
2019 25
2020 24
2021 26
2022 43
2023 34
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Prevention of postpartum hemorrhage in vaginal deliveries.
Angarita AM, Cochrane E, Bianco A, Berghella V. Angarita AM, et al. Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:112-119. doi: 10.1016/j.ejogrb.2022.11.021. Epub 2022 Nov 24. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 36455391 Review.
Measures for the prevention of PPH include identification and management of iron deficiency anemia, unit readiness and preparedness through performing regular simulations and having a PPH cart or medication kit readily available, prophylactic uterotonic - carbetocin alone …
Measures for the prevention of PPH include identification and management of iron deficiency anemia, unit readiness and preparedness through …
Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone.
Jones AJ, Federspiel JJ, Eke AC. Jones AJ, et al. Am J Obstet Gynecol MFM. 2023 Feb;5(2S):100731. doi: 10.1016/j.ajogmf.2022.100731. Epub 2022 Aug 24. Am J Obstet Gynecol MFM. 2023. PMID: 36028160 Free PMC article. Review.
Pharmacotherapy remains the first-line preventative therapy for postpartum hemorrhage. These therapies may be single (oxytocin, carbetocin, methylergonovine, ergometrine, misoprostol, prostaglandin analogs, or tranexamic acid) or combination therapies, acting in an additiv …
Pharmacotherapy remains the first-line preventative therapy for postpartum hemorrhage. These therapies may be single (oxytocin, carbetoci
Uterine atony.
Miller HE, Ansari JR. Miller HE, et al. Curr Opin Obstet Gynecol. 2022 Apr 1;34(2):82-89. doi: 10.1097/GCO.0000000000000776. Curr Opin Obstet Gynecol. 2022. PMID: 35102109 Review.
The optimal prophylactic dose of oxytocin differs depending on the patient population, but less than 5 units and as low as a fraction of one unit is needed for PPH prevention, with an increased requirements within that range for cesarean birth, those on magnesium, and advanced ma …
The optimal prophylactic dose of oxytocin differs depending on the patient population, but less than 5 units and as low as a fraction of one …
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A. Gallos ID, et al. Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2. Cochrane Database Syst Rev. 2018. PMID: 29693726 Free PMC article. Updated. Review.
This primarily impacted on our confidence in comparisons involving carbetocin trials more than other uterotonics.The three most effective drugs for prevention of PPH 500 mL were ergometrine plus oxytocin combination, carbetocin, and misoprostol plus oxytocin combina …
This primarily impacted on our confidence in comparisons involving carbetocin trials more than other uterotonics.The three most effec …
Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
McDonagh F, Carvalho JCA, Abdulla S, Cordovani D, Downey K, Ye XY, Farine D, Morais M, Balki M. McDonagh F, et al. Anaesthesia. 2022 Aug;77(8):892-900. doi: 10.1111/anae.15714. Epub 2022 Mar 28. Anaesthesia. 2022. PMID: 35343585 Free article. Clinical Trial.
In this double-blind, randomised, controlled, non-inferiority trial, we assigned low-risk patients undergoing elective caesarean delivery under spinal anaesthesia to one of four groups: carbetocin 20 mug; carbetocin 100 mug; oxytocin 0.5 IU bolus + infusion; and oxy …
In this double-blind, randomised, controlled, non-inferiority trial, we assigned low-risk patients undergoing elective caesarean delivery un …
Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents.
Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT. Jaffer D, et al. Am J Obstet Gynecol. 2022 Mar;226(3):347-365. doi: 10.1016/j.ajog.2021.08.060. Epub 2021 Sep 14. Am J Obstet Gynecol. 2022. PMID: 34534498 Review.
STUDY ELIGIBILITY CRITERIA: We included randomized controlled trials that compared oxytocin, carbetocin, misoprostol, ergometrine, carboprost, or combinations of these in the prevention of postpartum hemorrhage during cesarean delivery. ...For both primary outcomes, oxytoc …
STUDY ELIGIBILITY CRITERIA: We included randomized controlled trials that compared oxytocin, carbetocin, misoprostol, ergometrine, ca …
Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I, Williams H, Price M, Pickering K, Merriel A, Tobias A, Lissauer D, Gee H, Tunçalp Ö, Gyte G, Moorthy V, Roberts T, Deeks J, Hofmeyr J, Gülmezoglu M, Coomarasamy A. Gallos I, et al. Health Technol Assess. 2019 Feb;23(9):1-356. doi: 10.3310/hta23090. Health Technol Assess. 2019. PMID: 30821683 Free PMC article.
However, most carbetocin trials are small and of poor quality. There is a need for a large high-quality trial comparing carbetocin with oxytocin; such a trial is currently being conducted by the WHO. ...However, existing carbetocin studies were small and of p …
However, most carbetocin trials are small and of poor quality. There is a need for a large high-quality trial comparing carbetocin
Optimal uterotonic management.
Heesen M, Orbach-Zinger S. Heesen M, et al. Best Pract Res Clin Anaesthesiol. 2022 May;36(1):135-155. doi: 10.1016/j.bpa.2022.02.002. Epub 2022 Feb 10. Best Pract Res Clin Anaesthesiol. 2022. PMID: 35659950
Methylergometrine and carboprost should, therefore, be avoided in many cardiovascular pathologies. Carbetocin is a chemical modification of oxytocin with a longer half-time, and therefore one bolus of carbetocin is usually sufficient. ...
Methylergometrine and carboprost should, therefore, be avoided in many cardiovascular pathologies. Carbetocin is a chemical modificat …
Epidemiology, prevention and management of early postpartum hemorrhage - a systematic review.
Feduniw S, Warzecha D, Szymusik I, Wielgos M. Feduniw S, et al. Ginekol Pol. 2020;91(1):38-44. doi: 10.5603/GP.2020.0009. Ginekol Pol. 2020. PMID: 32039467 Free article.
Interestingly, the majority of uterotonics seem to have a similar effect. However, carbetocin seems to be the most effective in certain situations. Appropriate diagnosis of EPH is the most important issue. ...
Interestingly, the majority of uterotonics seem to have a similar effect. However, carbetocin seems to be the most effective in certa …
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, Williams MJ, Diaz V, Pasquale J, Chamillard M, Widmer M, Tunçalp Ö, Hofmeyr GJ, Althabe F, Gülmezoglu AM, Vogel JP, Oladapo OT, Coomarasamy A. Gallos ID, et al. Cochrane Database Syst Rev. 2018 Dec 19;12(12):CD011689. doi: 10.1002/14651858.CD011689.pub3. Cochrane Database Syst Rev. 2018. PMID: 30569545 Free PMC article.
Carbetocin, injectable prostaglandins and ergometrine plus oxytocin may also reduce the use of additional uterotonics but the certainty of the evidence is low. ...The two combination regimens, however, are associated with significant side effects. Carbetocin may be
Carbetocin, injectable prostaglandins and ergometrine plus oxytocin may also reduce the use of additional uterotonics but the certain
321 results